Skip to content

Can routine blood tests predict dangerous belly fat in Adults attending Routine Health Check-ups? A study to develop and validate an inexpensive, simple clinical Index

Development and validation of a novel clinical index for estimating visceral adiposity using routine anthropometric and biochemical parameters.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/111177
Enrollment
200
Registered
2026-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr Debarghya Dey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18 to 70 years attending Phoenix Medical Centre for routine clinical evaluation or health check-up Confirmed fasting state at the time of blood draw, defined as a minimum of 8 hours of fasting prior to venepuncture Availability of routine fasting biochemical investigations including lipid profile, liver function tests, fasting blood glucose, and complete blood count performed within the same clinical visit Willingness to provide written informed consent

Exclusion criteria

Exclusion criteria: Known chronic liver disease viral hepatitis (B or C), autoimmune hepatitis, primary biliary cholangitis, or established cirrhosis of any aetiology Significant alcohol intake Haematological disorders any condition known to independently affect platelet count, including immune thrombocytopenic purpura (ITP), myeloproliferative neoplasms, or haematological malignancies. This exclusion is based on structured clinical history of known pre-existing diagnosis only; no additional haematological screening investigations will be performed Incidentally detected markedly abnormal platelet count on routine bloods Acute illness any acute infective, inflammatory, or surgical condition at the time of enrolment, as these may transiently alter biochemical parameters Pregnancy in view of physiological alterations in body composition, lipid profile, liver enzymes, and platelet count Refusal or inability to provide informed consent Unavailability of required fasting biochemical parameters from the same clinical visit

Design outcomes

Primary

MeasureTime frame
Triglycerides HDL Cholesterol Fasting Blood Glucose Alanine Aminotransferase (ALT) Gamma-Glutamyl Transferase (GGT) Platelet Count Timepoint: Triglycerides HDL Cholesterol Fasting Blood Glucose Alanine Aminotransferase (ALT) Gamma-Glutamyl Transferase (GGT) Platelet Count

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDebarghya Dey

Phoenix Medical Centre

ddey1987@gmail.com9674351947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026